J Kevin Buchi Alaunos Therapeutics, Inc. (TCRT) insider trading activity

TCRT Quotes by TradingView

J Kevin Buchi is Director of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 4,167 shares of TCRT, which is worth approximately $9,500. The most recent transaction as insider was on Mar 04, 2021, when has been sold 4,167 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.17K
0% 3M change
0% 12M change
Total Value Held $9,500

J KEVIN BUCHI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2021
BUY
Grant, award, or other acquisition
-
4,167 Added 50.0%
4,167 Common Stock

Also insider at

AMRX
Amneal Pharmaceuticals, Inc. Healthcare
Director
AMPE
Ampio Pharmaceuticals, Inc. Healthcare
Director
BNTC
Benitec Biopharma Inc. Healthcare
Director
DRNA
Dicerna Pharmaceuticals Inc
Director
JKB

J Kevin Buchi

Director
Boston, MA

Track Institutional and Insider Activities on TCRT

Follow Alaunos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

News

Receive news related to Alaunos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRT